{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:02:02Z","timestamp":1795089722404,"version":"4.10.2"},"reference-count":165,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic fatty liver disease (NAFLD) represents a growing cause of chronic liver injury, especially in western countries, where it is becoming the most frequent indication for liver transplantation. Nonalcoholic fatty liver disease encompasses a spectrum of diseases that from simple steatosis (pure NAFLD) can progress to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. The pathogenesis of NAFLD and the mechanisms behind its progression to NASH have been extensively studied. However, although the processes that determine fat accumulation are mostly clear, the mechanisms associated with the progression of the disease are not fully characterized. In predisposed patients, lipid accumulation can promote lipotoxicity and mitochondrial dysfunction, thus triggering hepatocyte death, inflammation and fibrosis. The specific role of different lipids has been identified and free fatty acids as well as free cholesterol have been identified as toxic species. To make the picture more complex, the pathogenesis of NAFLD involves pathological connections between several organs, including the adipose tissue and the gut, with the liver. The \u201cinflamed\u201d adipose tissue plays a key role in the release of toxic lipids, whereas alterations in the gut-liver axis have been associated with the progression from NAFLD to NASH mediated by dysbiosis, alteration of intestinal barrier, and finally bacterial translocation, which can trigger proinflammatory and profibrogenetic pathways, finally leading to cirrhosis development.<\/jats:p>","DOI":"10.1097\/tp.0000000000002480","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T15:43:32Z","timestamp":1539099812000},"page":"e1-e13","source":"Crossref","is-referenced-by-count":452,"title":["Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH"],"prefix":"10.1097","volume":"103","author":[{"given":"Irene","family":"Pierantonelli","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Universit\u00e0 Politecnica delle Marche, Ancona, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Svegliati-Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","year":"2016","journal-title":"Clin Liver Dis"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: current burden and expected challenges","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","year":"2005","journal-title":"J Clin Invest"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1038\/nutd.2014.43","article-title":"Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity","volume":"5","year":"2015","journal-title":"Nutr Diabetes"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","year":"2017","journal-title":"J Clin Invest"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","year":"2017","journal-title":"J Pathol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","article-title":"Animal models of nonalcoholic fatty liver disease","volume":"8","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","year":"2012","journal-title":"World J Gastroenterol"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.21874","article-title":"Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","year":"2004","journal-title":"J Hepatol"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"e97136","DOI":"10.1371\/journal.pone.0097136","article-title":"HCC development is associated to peripheral insulin resistance in a mouse model of NASH","volume":"9","year":"2014","journal-title":"PloS One"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2018.05.002","article-title":"Towards a definite mouse model of NAFLD","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1038\/ncomms14859","article-title":"Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice","volume":"8","year":"2017","journal-title":"Nat Commun"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism","volume":"281","year":"2006","journal-title":"J Biol Chem"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","year":"2012","journal-title":"Cell"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1073\/pnas.1423952112","article-title":"Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids","volume":"112","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","year":"2013","journal-title":"J Gastroenterol"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","year":"2016","journal-title":"Biol Rev Camb Philos Soc"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cmet.2013.04.021","article-title":"Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance","volume":"18","year":"2013","journal-title":"Cell Metab"},{"issue":"Suppl 4","key":"bib26-20231002","first-page":"81","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"E1724","DOI":"10.1152\/ajpendo.00717.2006","article-title":"A high-fat, ketogenic diet induces a unique metabolic state in mice","volume":"292","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib28-20231002","article-title":"Molecular pathogenesis of NASH","volume":"17","year":"2016","journal-title":"Int J Mol Sci"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","year":"2013","journal-title":"J Hepatol"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/19490976.2015.1086057","article-title":"The colonic mucus protection depends on the microbiota","volume":"6","year":"2015","journal-title":"Gut Microbes"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI0216886","article-title":"Orchestrating the unfolded protein response in health and disease","volume":"110","year":"2002","journal-title":"J Clin Invest"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2011.05.019","article-title":"Lipotoxicity in NASH","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","year":"2015","journal-title":"J Lipid Res"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature09968","article-title":"Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity","volume":"473","year":"2011","journal-title":"Nature"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","year":"2016","journal-title":"J Lipid Res"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","year":"2006","journal-title":"Endocrinology"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"E1027","DOI":"10.1152\/ajpendo.00642.2009","article-title":"Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C\/EBP homologous protein and chemical chaperones in palmitate-mediated cell death","volume":"298","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"39336","DOI":"10.1074\/jbc.M111.280420","article-title":"Death receptor 5 signaling promotes hepatocyte lipoapoptosis","volume":"286","year":"2011","journal-title":"J Biol Chem"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.1217611110","article-title":"Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.onc.1210638","article-title":"Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis","volume":"27","year":"2008","journal-title":"Oncogene"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","year":"2011","journal-title":"Nat Cell Biol"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"287","year":"2000","journal-title":"Science"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1123480","article-title":"Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha","volume":"312","year":"2006","journal-title":"Science"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3748\/wjg.v20.i7.1768","article-title":"Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","year":"1995","journal-title":"Immunity"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jhep.2014.11.033","article-title":"TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-induced signaling causes release of inflammatory extracellular vesicles from Hepatocytes","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41598-017-01721-4","article-title":"Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep4.1069","article-title":"TRAIL deletion prevents liver, but not adipose tissue, inflammation during murine diet-induced obesity","volume":"1","year":"2017","journal-title":"Hepatol Commun"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2015.01.032","article-title":"Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity","volume":"62","year":"2015","journal-title":"J Hepatol"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2013.10.009","article-title":"Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes","volume":"63","year":"2014","journal-title":"Metabolism"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","article-title":"Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","year":"1995","journal-title":"J Clin Invest"},{"key":"bib57-20231002","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"bib58-20231002","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1572-0241.2005.41500.x","article-title":"Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease","volume":"100","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"bib59-20231002","first-page":"2862173","article-title":"The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background","volume":"2016","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"bib60-20231002","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.20683","article-title":"Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"bib61-20231002","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2353\/ajpath.2006.050953","article-title":"A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury","volume":"169","year":"2006","journal-title":"Am J Pathol"},{"key":"bib62-20231002","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1478-3231.2012.02860.x","article-title":"Endoplasmic reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"bib63-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0676.2001.210101.x","article-title":"Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells","volume":"21","year":"2001","journal-title":"Liver"},{"key":"bib64-20231002","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies","volume":"28","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"bib65-20231002","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","year":"2011","journal-title":"Cell Metab"},{"key":"bib66-20231002","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2010.05.039","article-title":"Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"bib67-20231002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","year":"2015","journal-title":"Cell Metab"},{"key":"bib68-20231002","doi-asserted-by":"crossref","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","article-title":"Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity","volume":"310","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib69-20231002","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.aaa0672","article-title":"Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats","volume":"347","year":"2015","journal-title":"Science"},{"key":"bib70-20231002","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"bib71-20231002","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","year":"2007","journal-title":"Hepatology"},{"key":"bib72-20231002","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cmet.2016.10.012","article-title":"Physiological suppression of lipotoxic liver damage by complementary actions of HDAC3 and SCAP\/SREBP","volume":"24","year":"2016","journal-title":"Cell Metab"},{"key":"bib73-20231002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hep.25601","article-title":"Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice","volume":"56","year":"2012","journal-title":"Hepatology"},{"key":"bib74-20231002","doi-asserted-by":"crossref","first-page":"14890","DOI":"10.1074\/jbc.M010286200","article-title":"Palmitate-induced apoptosis can occur through a ceramide-independent pathway","volume":"276","year":"2001","journal-title":"J Biol Chem"},{"key":"bib75-20231002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/diabetes.50.1.69","article-title":"Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function","volume":"50","year":"2001","journal-title":"Diabetes"},{"key":"bib76-20231002","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0022-2275(20)37421-6","article-title":"Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes","volume":"38","year":"1997","journal-title":"J Lipid Res"},{"key":"bib77-20231002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-011-1211-9","article-title":"Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK\/ATF4\/CHOP signaling pathway","volume":"364","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"bib78-20231002","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1194\/jlr.M050237","article-title":"Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells","volume":"55","year":"2014","journal-title":"J Lipid Res"},{"key":"bib79-20231002","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.molmet.2014.05.004","article-title":"ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload","volume":"3","year":"2014","journal-title":"Mol Metab"},{"key":"bib80-20231002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2011.10.018","article-title":"Accumulation of endoplasmic reticulum stress and lipogenesis in the liver through generational effects of high fat diets","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"bib81-20231002","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","year":"2009","journal-title":"J Biol Chem"},{"key":"bib82-20231002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2010.01.003","article-title":"Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"bib83-20231002","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"bib84-20231002","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.febslet.2010.01.046","article-title":"Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice","volume":"584","year":"2010","journal-title":"FEBS Lett"},{"key":"bib85-20231002","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"bib86-20231002","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","article-title":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"bib87-20231002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","year":"2006","journal-title":"Cell Metab"},{"key":"bib88-20231002","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"bib89-20231002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"bib90-20231002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic Steatosis","volume":"22","year":"2015","journal-title":"Cell Metab"},{"key":"bib91-20231002","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","year":"2005","journal-title":"Science"},{"key":"bib92-20231002","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","year":"2018","journal-title":"Gut"},{"key":"bib93-20231002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","article-title":"The role of the gut microbiota in nutrition and health","volume":"9","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib94-20231002","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2016.02.073","article-title":"Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects?","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"bib95-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2008.10.080","article-title":"Microbes in gastrointestinal health and disease","volume":"136","year":"2009","journal-title":"Gastroenterology"},{"key":"bib96-20231002","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","article-title":"The gut microbiota\u2013masters of host development and physiology","volume":"11","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"bib97-20231002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","year":"2006","journal-title":"Nature"},{"key":"bib98-20231002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib99-20231002","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","year":"2013","journal-title":"J Lipid Res"},{"key":"bib100-20231002","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"bib101-20231002","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.dld.2014.02.010","article-title":"Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity","volume":"46","year":"2014","journal-title":"Dig Liver Dis"},{"key":"bib102-20231002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"bib103-20231002","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.26695","article-title":"Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"bib104-20231002","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"bib105-20231002","doi-asserted-by":"crossref","first-page":"17568","DOI":"10.1038\/s41598-017-17187-3","article-title":"Author correction: lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib106-20231002","first-page":"E5934","article-title":"High-fat diet modifies the PPAR-\u03b3 pathway leading to disruption of microbial and physiological ecosystem in murine small intestine","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib107-20231002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"bib108-20231002","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and toll-like receptors in nonalcoholic fatty liver disease","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib109-20231002","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1042\/CS20160838","article-title":"TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival","volume":"131","year":"2017","journal-title":"Clin Sci"},{"key":"bib110-20231002","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"bib111-20231002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","year":"2010","journal-title":"Gastroenterology"},{"key":"bib112-20231002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"bib113-20231002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fj.09-141929","article-title":"Tlr2 is critical for diet-induced metabolic syndrome in a murine model","volume":"24","year":"2010","journal-title":"FASEB J"},{"key":"bib114-20231002","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","year":"2007","journal-title":"Diabetes"},{"key":"bib115-20231002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"bib116-20231002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","year":"2007","journal-title":"J Hepatol"},{"key":"bib117-20231002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","year":"2012","journal-title":"Cancer Cell"},{"key":"bib118-20231002","first-page":"E1306","article-title":"Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice","volume":"113","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib119-20231002","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","year":"2013","journal-title":"Nature"},{"key":"bib120-20231002","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in non-alcoholic fatty liver disease","journal-title":"Hepatology"},{"key":"bib121-20231002","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.2010.60","article-title":"Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis","volume":"90","year":"2010","journal-title":"Lab Invest"},{"key":"bib122-20231002","doi-asserted-by":"crossref","first-page":"e93909","DOI":"10.1371\/journal.pone.0093909","article-title":"Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites","volume":"9","year":"2014","journal-title":"PloS One"},{"key":"bib123-20231002","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"bib124-20231002","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","year":"2008","journal-title":"Gastroenterology"},{"key":"bib125-20231002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","year":"2003","journal-title":"J Hepatol"},{"key":"bib126-20231002","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","year":"2015","journal-title":"Am J Pathol"},{"key":"bib127-20231002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2015.12.010","article-title":"Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"bib128-20231002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"bib129-20231002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"bib130-20231002","doi-asserted-by":"crossref","first-page":"15433","DOI":"10.1038\/ncomms15433","article-title":"Non-cell-autonomous activation of IL-6\/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis","volume":"8","year":"2017","journal-title":"Nat Commun"},{"key":"bib131-20231002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jhep.2017.01.027","article-title":"Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19\/FGF15","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"bib132-20231002","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice","volume":"1","year":"2017","journal-title":"Hepatol Commun"},{"key":"bib133-20231002","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","article-title":"NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"bib134-20231002","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"bib135-20231002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"bib136-20231002","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"bib137-20231002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","year":"2012","journal-title":"Nature"},{"key":"bib138-20231002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","year":"2014","journal-title":"J Mol Med"},{"key":"bib139-20231002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","year":"2011","journal-title":"Nat Med"},{"key":"bib140-20231002","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib141-20231002","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","year":"2014","journal-title":"Gastroenterology"},{"key":"bib142-20231002","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"bib143-20231002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"bib144-20231002","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","year":"2015","journal-title":"J Clin Invest"},{"key":"bib145-20231002","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","year":"2014","journal-title":"Cancer Cell"},{"key":"bib146-20231002","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","year":"2011","journal-title":"J Clin Immunol"},{"key":"bib147-20231002","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","article-title":"The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis","volume":"32","year":"2012","journal-title":"J Clin Immunol"},{"key":"bib148-20231002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","year":"2011","journal-title":"Clini Exp Immunol"},{"key":"bib149-20231002","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrendo.2012.114","article-title":"Adaptive immunity in obesity and insulin resistance","volume":"8","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"bib150-20231002","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.0908771107","article-title":"Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in Ob\/Ob mice","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib151-20231002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.2011.04511.x","article-title":"Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells","volume":"167","year":"2012","journal-title":"Clini Exp Immunol"},{"key":"bib152-20231002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/path.1869","article-title":"Amelioration of non-alcoholic steatohepatitis and glucose intolerance in Ob\/Ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels","volume":"208","year":"2006","journal-title":"J Pathol"},{"key":"bib153-20231002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10875-015-0160-6","article-title":"Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo-controlled trial","volume":"35","year":"2015","journal-title":"J Clin Immunol"},{"key":"bib154-20231002","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"bib155-20231002","doi-asserted-by":"crossref","first-page":"e11518","DOI":"10.1097\/MD.0000000000011518","article-title":"Liver transplantation (LT) for cryptogenic cirrhosis (CC) and nonalcoholic steatohepatitis (NASH) cirrhosis: data from the scientific registry of transplant recipients (SRTR): 1994 to 2016","volume":"97","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"bib156-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"bib157-20231002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"12","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib158-20231002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/jlts.2001.23011","article-title":"Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib159-20231002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.TP.0000436723.59879.01","article-title":"Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib160-20231002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cld.2016.12.006","article-title":"De novo and recurrence of nonalcoholic Steatohepatitis after liver transplantation","volume":"21","year":"2017","journal-title":"Clin Liver Dis"},{"key":"bib161-20231002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.24509","article-title":"Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"bib162-20231002","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/bj20031320","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone","volume":"378","year":"2004","journal-title":"Biochem J"},{"key":"bib163-20231002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.20926","article-title":"Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"bib164-20231002","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.metabol.2014.02.004","article-title":"Short and long term in vivo effects of cyclosporine A and sirolimus on genes and proteins involved in lipid metabolism in Wistar rats","volume":"63","year":"2014","journal-title":"Metabolism"},{"key":"bib165-20231002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bcp.2014.01.020","article-title":"Molecular mechanisms underlying the effects of cyclosporin a and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model","volume":"88","year":"2014","journal-title":"Biochem Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:19:01Z","timestamp":1696209541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201901000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002480","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}